Nykredit A/S’s Amgen AMGN Stock Holding History

Nykredit A/S’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.2M	Buy	+149,626	New	+$51.2M	0.17%	106

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Nykredit A/S's AMGN Position: Q2 2026 in Review

Nykredit A/S opened a new position in Amgen (AMGN) in Q2 2026: 149,626 shares worth $54.2M. The stake represents 0.17% of the portfolio and ranks #106 among its holdings.

2,691 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Nykredit A/S held 149,626 shares of Amgen worth $54.2M as of Q2 2026.
Amgen was a new Nykredit A/S position in Q2 2026.
Amgen made up 0.17% of Nykredit A/S's portfolio in Q2 2026, its #106 holding.
2,691 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.